National Cancer Institute
U.S. National Institutes of Health |

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
About NCI
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

NCI Highlights
The Cancer Genome Atlas Reports Brain Tumors Study

NCI Launches Community Cancer Centers Pilot

The Nation's Investment in Cancer Research FY 2009

NCI Strategic Plan for Leading the Nation

NCI Training and Career Development Inventory

Cancer Trends Progress Report: 2007 Update

NCI Participation in the NIH Roadmap

Past Highlights
   The Director's Corner
    Back to Main             Printable Version

Funding Opportunities at NCI

Using Health Claims Data for Cancer Surveillance
Full title: Cancer Surveillance Using Health Claims-Based Data System

PA Number: PA-04-012

The National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ) are seeking investigator-initiated grant applications for research involving the use of health care claims data for surveillance. Cancer surveillance may include assessing patterns of care, quality and outcomes of care, and health disparities. Research projects may focus on treatment and outcomes at the patient level or address influences from the broader health care system level. This research can also include analyses of how health claims data can be used for cancer surveillance.

This grant covers priority areas for both NCI and AHRQ. In the report entitled, "The Nation's Investment in Cancer Research," NCI addresses its priorities, including improving the quality of cancer care and reducing cancer-related health disparities. AHRQ supports general health services and outcomes and effectiveness research for a wide range of clinical conditions, including cancer.

Increasingly, there is interest in collecting and analyzing valid, accurate, and reliable secondary data to assess screening, treatment, and outcomes for specific diseases.

This initiative will utilize the NIH investigator-initiated research project grant (R01) and the exploratory/developmental grant (R21) award mechanisms. The total project period for an application being submitted must not exceed five years (R01) or two years (R21).

Deadlines: Applications submitted in response to this program announcement will be accepted at the standard application deadlines, which are available at Application deadlines are also indicated in the PHS 398 application kit.


Direct your questions about scientific/research issues to:

Joan Warren, Ph.D.
Division of Cancer Control and Population Sciences
Applied Research Program
Phone (301) 496-5184, Fax (301) 435-3710

Bernard Friedman, Ph.D.
Agency for Healthcare Research and Quality
Phone (301) 427-1404

For questions about financial or grants management matters:

Crystal Wolfrey
Grants Administration Branch
Phone (301) 496-8634, Fax (301) 496-8601

Mable Lam
Agency for Healthcare Research and Quality
Phone (301) 427-1448

Additional information is available at

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health